COMMUNIQUÉS West-GlobeNewswire

Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments

29/02/2024 - 22:05

Record DANYELZA® net product revenues of $ 23.4 million and $84.3 million for Q4 and FY 2023 represents YoY growth of 42 % and 71%, respectively Cash and cash equivalents of $ 78.6 million as of December 31, 2023; [...]

AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement

29/02/2024 - 22:02

VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

29/02/2024 - 22:01

XEN1101 Phase 3 epilepsy program continues to progress with X-TOLE2 and X-TOLE3 in focal onset seizures and X-ACKT in primary generalized tonic-clonic seizures; completion of patient enrollment in X-TOLE2 expected in [...]

PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights

29/02/2024 - 22:01

Registrational, tumor-agnostic Phase 2 portion of PYNNACLE clinical trial of rezatapopt (PC14586), a first-in-class precision oncology investigational therapy in patients with advanced solid tumors with a TP53 Y220C [...]

Nextech to Unveil Patient Journey Innovations Driven by AI for Specialty Practices at 10th Annual EDGE User Conference

29/02/2024 - 20:18

TAMPA, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Nextech, a leading provider of clinical and administrative healthcare technology solutions for specialty physician practices, today announced clients will be the first to [...]

Opération de regroupement d'actions

29/02/2024 - 18:00

Communiqué de presse Ecully, le 29 février 2024 – 18h Prise d’effet du regroupement des actions Spineway Spineway annonce la finalisation de l’opération de regroupement de ses actions par échange de 1 action nouvelle de [...]

Reverse stock split

29/02/2024 - 18:00

Press release Ecully, February 29, 2024 – 6:00 p.m. Effective date of the Spineway reverse stock split Spineway announces the completion of the reverse stock split by exchanging 1 new share of 4.00 euros par value for 2 [...]

NTG Nordic Transport Group A/S – Notice to convene the Annual General Meeting 2024

29/02/2024 - 17:49

Company announcement no. 3 – 24 29 February 2024 NTG Nordic Transport Group A/S – Notice to convene the Annual General Meeting 2024 The Annual General Meeting of NTG Nordic Transport Group A/S will be held on Thursday, [...]

Health Advocate Applauds Federal Government in Free Access to Contraceptives for Canadians

29/02/2024 - 17:15

OTTAWA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The Society of Obstetricians and Gynaecologist of Canada (SOGC) applauds the Canadian government on today’s historic announcement to include free access for prescription [...]

Les professionnels de la santé applaudissent le gouvernement fédéral pour l'accès gratuit aux contraceptifs pour les Canadiens

29/02/2024 - 17:15

OTTAWA, 29 févr. 2024 (GLOBE NEWSWIRE) -- La Société des obstétriciens et gynécologues du Canada (SOGC) applaudit l’annonce historique du gouvernement canadien visant à inclure l'accès gratuit aux méthodes [...]

NTG Nordic Transport Group Annual Report for 2023

29/02/2024 - 17:12

Company announcement no. 2 – 24 29 February 2024 NTG Nordic Transport Group Annual Report for 2023 NTG Nordic Transport Group A/S (“NTG”) has today published the 2023 annual report. Selected financial highlights are [...]

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

29/02/2024 - 16:48

Company Announcement COPENHAGEN, Denmark; February 29, 2024 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]

DAS Health Expands Reach to Senior Living Organizations with Recent Acquisition

29/02/2024 - 16:11

Tampa, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) -- DAS Health, a provider of healthcare IT and business solutions, proudly announces the acquisition of Agility Holdings, LLC d/b/a vcpi. This significant acquisition expands [...]

Synaptive Medical Welcomes Chris Marrus as New Chief Commercial Officer

29/02/2024 - 16:00

New position of Chief Commercial Officer established to drive sales and growth for Synaptive Chris Marrus brings extensive experience in innovative med tech to Synaptive having held senior leadership roles at INSIGHTEC [...]

Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

29/02/2024 - 16:00

BOSTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells [...]

Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

29/02/2024 - 15:15

ATLANTA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic [...]

Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting

29/02/2024 - 15:15

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president [...]

Capsa Announces NexPak Automated Medication Packaging System

29/02/2024 - 15:12

COLUMBUS, Ohio, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Capsa Healthcare , a leader in advanced healthcare workflow solutions, announces the new NexPak Automated Packaging System . NexPak gives pharmacies the most direct path [...]

AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference

29/02/2024 - 15:00

VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]